Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey

Total article views   HTML views PDF downloads Totals
12,500 Dovepress* 11,114+ 1,793 12,907
PubMed Central* 1,386 581 1,967
Totals 12,500 2,374 14,874
*Since 23 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed and Google Scholar